Papers
4
Total Citations
136
H-Index
4
About
Dr. King‑Teh Lee is a pioneering minimally invasive surgeon whose research centers on robotic and laparoscopic approaches to hepatobiliary surgery, particularly cholecystectomy and hepatocellular carcinoma (HCC) resection. His landmark 2016 study comparing single‑site robotic cholecystectomy (SSRC) to single‑incision laparoscopic cholecystectomy (SILC) demonstrated that robotic technology overcomes manual limitations while maintaining safety—a work cited 52 times. In 2017, he published a critical analysis of robotic versus conventional laparoscopic cholecystectomy, examining both clinical outcomes and medical resource utilization (44 citations), providing essential data for cost‑benefit discussions in surgical robotics. Dr. Lee’s contributions extend to oncologic surgery, with his 2018 investigation into robotic hepatoma resection (34 citations) advancing the evidence for robotic approaches in liver cancer. Most recently, his 2022 prospective cohort study applied inverse probability of treatment weighting to compare long‑term quality‑of‑life outcomes across three surgical procedures for HCC, involving 520 patients. This methodologically rigorous work underscores his commitment to patient‑centered outcomes. Dr. Lee’s research consistently bridges technological innovation with practical clinical evaluation, making him a key voice in the evolution of robotic hepatobiliary surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3Oncological and surgical result of hepatoma after robot surgery34 citations · 2018
- 4